These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35608921)

  • 1. Small-molecule inhibitor of intestinal anion exchanger SLC26A3 for treatment of hyperoxaluria and nephrolithiasis.
    Cil O; Chu T; Lee S; Haggie PM; Verkman AS
    JCI Insight; 2022 Jul; 7(13):. PubMed ID: 35608921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC26A3 inhibitor identified in small molecule screen blocks colonic fluid absorption and reduces constipation.
    Haggie PM; Cil O; Lee S; Tan JA; Rivera AA; Phuan PW; Verkman AS
    JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcellular oxalate and Cl- absorption in mouse intestine is mediated by the DRA anion exchanger Slc26a3, and DRA deletion decreases urinary oxalate.
    Freel RW; Whittamore JM; Hatch M
    Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(7):G520-7. PubMed ID: 23886857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC26A6-selective inhibitor identified in a small-molecule screen blocks fluid absorption in small intestine.
    Cil O; Haggie PM; Tan JT; Rivera AA; Verkman AS
    JCI Insight; 2021 Jun; 6(11):. PubMed ID: 34100381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia.
    Whittamore JM; Stephens CE; Hatch M
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G82-G94. PubMed ID: 30383413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential roles of CFEX-mediated Cl(-)-oxalate exchange in proximal tubule NaCl transport and prevention of urolithiasis.
    Aronson PS
    Kidney Int; 2006 Oct; 70(7):1207-13. PubMed ID: 16883319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule inhibitors of intestinal epithelial anion exchanger SLC26A3 (DRA) with a luminal, extracellular site of action.
    Cil O; Anderson MO; de Souza Goncalves L; Tan JA; Haggie PM; Verkman AS
    Eur J Med Chem; 2023 Mar; 249():115149. PubMed ID: 36724632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.
    Amin R; Asplin J; Jung D; Bashir M; Alshaikh A; Ratakonda S; Sharma S; Jeon S; Granja I; Matern D; Hassan H
    Kidney Int; 2018 May; 93(5):1098-1107. PubMed ID: 29395336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. slc26a3 (dra)-deficient mice display chloride-losing diarrhea, enhanced colonic proliferation, and distinct up-regulation of ion transporters in the colon.
    Schweinfest CW; Spyropoulos DD; Henderson KW; Kim JH; Chapman JM; Barone S; Worrell RT; Wang Z; Soleimani M
    J Biol Chem; 2006 Dec; 281(49):37962-71. PubMed ID: 17001077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperoxaluria in a Model of Mini-Gastric Bypass Surgery in Rats.
    Ormanji MS; Korkes F; Meca R; Ishiy CSRA; Finotti GHC; Ferraz RRN; Heilberg IP
    Obes Surg; 2017 Dec; 27(12):3202-3208. PubMed ID: 28550437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of the anion exchanger DRA (Slc26a3), or PAT1 (Slc26a6), alters sulfate transport by the distal ileum and overall sulfate homeostasis.
    Whittamore JM; Hatch M
    Am J Physiol Gastrointest Liver Physiol; 2017 Sep; 313(3):G166-G179. PubMed ID: 28526688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.
    Langman CB; Grujic D; Pease RM; Easter L; Nezzer J; Margolin A; Brettman L
    Am J Nephrol; 2016; 44(2):150-8. PubMed ID: 27529510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of intestinal Cl-/HCO3- exchanger SLC26A3 by intracellular pH.
    Hayashi H; Suruga K; Yamashita Y
    Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1279-90. PubMed ID: 19321737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
    Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
    Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant negative mutation in oxalate transporter
    Cornière N; Thomson RB; Thauvin S; Villoutreix BO; Karp S; Dynia DW; Burlein S; Brinkmann L; Badreddine A; Dechaume A; Derhourhi M; Durand E; Vaillant E; Froguel P; Chambrey R; Aronson PS; Bonnefond A; Eladari D
    J Med Genet; 2022 Nov; 59(11):1035-1043. PubMed ID: 35115415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria.
    Takei K; Ito H; Masai M; Kotake T
    Urol Int; 1998; 61(3):192-5. PubMed ID: 9933846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of enteric oxalate secretion by Oxalobacter formigenes in mice does not require the presence of either apical oxalate transport proteins Slc26A3 or Slc26A6.
    Hatch M
    Urolithiasis; 2020 Feb; 48(1):1-8. PubMed ID: 31201468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxalate: from physiology to pathology].
    Grocholski C; Derain Dubourg L; Guebre-Egziabher F; Acquaviva-Bourdain C; Abid N; Bacchetta J; Chambrier C; Lemoine S
    Nephrol Ther; 2023 Jun; 19(3):201-214. PubMed ID: 37166780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.